CCL2 and obesity disorder: Elucidating the details of the mechanisms underlying reduced MCP-1 expression in response to AMPK activation in hypertrophied 3T3-L1 adipocytes may open the way to new therapeutic strategies for obesity-induced inflammation and insulin resistance.